<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Experimental and observational studies have suggested that <z:chebi fb="3" ids="37445">folate</z:chebi> may play dual roles in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk depending on the timing and dose </plain></SENT>
<SENT sid="1" pm="."><plain>OBJECTIVE: We examined the latency between <z:chebi fb="3" ids="37445">folate</z:chebi> intake and the incidence of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN: We prospectively examined associations between <z:chebi fb="3" ids="37445">folate</z:chebi> intake assessed every 2 to 4 y by using validated food-frequency questionnaires and risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and <z:mpath ids='MPATH_270'>adenoma</z:mpath> in the Nurses' Health Study and Health Professionals Follow-Up Study, which included 2299 incident <z:e sem="disease" ids="C1527249" disease_type="Neoplastic Process" abbrv="">colorectal cancers</z:e> and 5655 colorectal <z:mpath ids='MPATH_270'>adenomas</z:mpath> from 1980 to 2004 </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: There was an association between total <z:chebi fb="3" ids="37445">folate</z:chebi> intake 12-16 y before diagnosis and lower risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (relative risk: 0.69; 95% CI: 0.51, 0.94; ≥800 compared with &lt;250 μg <z:chebi fb="3" ids="37445">folate</z:chebi>/d), but there was no association between intake in the recent past and <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> risk </plain></SENT>
<SENT sid="4" pm="."><plain>Long- and short-term intakes of total <z:chebi fb="3" ids="37445">folate</z:chebi> were associated with a lower risk of colorectal <z:mpath ids='MPATH_270'>adenoma</z:mpath>, with a strong association with intake 4-8 y before diagnosis (odds ratio: 0.68; 95% CI: 0.60, 0.78; ≥800 compared with &lt;250 μg <z:chebi fb="3" ids="37445">folate</z:chebi>/d) </plain></SENT>
<SENT sid="5" pm="."><plain>The current use of multivitamins for &gt;15 y, but not a shorter duration of use, was associated with lower risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>; and a shorter duration of use was related to lower risk of <z:mpath ids='MPATH_270'>adenoma</z:mpath> </plain></SENT>
<SENT sid="6" pm="."><plain>We did not observe an adverse effect of total <z:chebi fb="3" ids="37445">folate</z:chebi> or synthetic <z:chebi fb="9" ids="27470">folic acid</z:chebi> on risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> or <z:mpath ids='MPATH_270'>adenoma</z:mpath> even during the <z:chebi fb="9" ids="27470">folic acid</z:chebi> fortification era </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: <z:chebi fb="3" ids="37445">Folate</z:chebi> intake is inversely associated with risk of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> only during early preadenoma stages </plain></SENT>
</text></document>